We are pleased to share with you the exciting news that Medasense has received AMAR approval to sell our pain (Nociception) monitoring system in Israel!
Israeli anaesthesiologists are now able to join their European colleagues, who are already using our technology to optimize and personalize intraoperative analgesic administration.
This is a significant milestone for Medasense. We are very proud to enter our home market, where our technology was developed!